| Lisa M Passarelli, PT | |
|
25 Pleasant St, Cheektowaga, NY 14225-3526 | |
| (716) 390-4785 | |
| Not Available |
| Full Name | Lisa M Passarelli |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 22 Years |
| Location | 25 Pleasant St, Cheektowaga, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154347755 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 025758 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Practitioner Services Of Wny Pc | 2668864968 | 8 |
News Archive
A network of emotion-regulating brain regions implicated in the pathological worry that can grip patients with anxiety disorders may also be useful for predicting the benefits of treatment.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.
Childhood obesity in the United States has more than tripled in the past three decades, and prior research has linked maternal employment to children's body mass index (BMI), a measure of their weight-for-height. A new study in the January/February issue of the journal Child Development has found that children's BMI rose the more years their mothers worked over their children's lifetimes.
› Verified 9 days ago
| Provider Name | People Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922073774 PECOS PAC ID: 3375457765 Enrollment ID: O20040203000739 |
News Archive
A network of emotion-regulating brain regions implicated in the pathological worry that can grip patients with anxiety disorders may also be useful for predicting the benefits of treatment.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.
Childhood obesity in the United States has more than tripled in the past three decades, and prior research has linked maternal employment to children's body mass index (BMI), a measure of their weight-for-height. A new study in the January/February issue of the journal Child Development has found that children's BMI rose the more years their mothers worked over their children's lifetimes.
› Verified 9 days ago
| Provider Name | State Of New York Comptrollers Office |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1316088941 PECOS PAC ID: 0840101770 Enrollment ID: O20190313000800 |
News Archive
A network of emotion-regulating brain regions implicated in the pathological worry that can grip patients with anxiety disorders may also be useful for predicting the benefits of treatment.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.
Childhood obesity in the United States has more than tripled in the past three decades, and prior research has linked maternal employment to children's body mass index (BMI), a measure of their weight-for-height. A new study in the January/February issue of the journal Child Development has found that children's BMI rose the more years their mothers worked over their children's lifetimes.
› Verified 9 days ago
| Provider Name | Medical Practitioner Services Of Wny Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376129015 PECOS PAC ID: 2668864968 Enrollment ID: O20220119000028 |
News Archive
A network of emotion-regulating brain regions implicated in the pathological worry that can grip patients with anxiety disorders may also be useful for predicting the benefits of treatment.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.
Childhood obesity in the United States has more than tripled in the past three decades, and prior research has linked maternal employment to children's body mass index (BMI), a measure of their weight-for-height. A new study in the January/February issue of the journal Child Development has found that children's BMI rose the more years their mothers worked over their children's lifetimes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa M Passarelli, PT 25 Pleasant St, Cheektowaga, NY 14225-3526 Ph: (716) 390-4785 | Lisa M Passarelli, PT 25 Pleasant St, Cheektowaga, NY 14225-3526 Ph: (716) 390-4785 |
News Archive
A network of emotion-regulating brain regions implicated in the pathological worry that can grip patients with anxiety disorders may also be useful for predicting the benefits of treatment.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.
Childhood obesity in the United States has more than tripled in the past three decades, and prior research has linked maternal employment to children's body mass index (BMI), a measure of their weight-for-height. A new study in the January/February issue of the journal Child Development has found that children's BMI rose the more years their mothers worked over their children's lifetimes.
› Verified 9 days ago
Marie Crawford, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3620 Harlem Rd Ste 2, Cheektowaga, NY 14215 Phone: 716-446-9500 Fax: 716-446-9501 | |
Dr. Michael S Brogan, PT, DPT, PHD Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2355 Union Rd, Cheektowaga, NY 14227 Phone: 716-825-1730 | |
Christin M Fisher, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4635 Union Rd, Cheektowaga, NY 14225 Phone: 716-505-5700 Fax: 716-633-9351 | |
Camillia J Mcklevis, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4635 Union Rd, Cheektowaga, NY 14225 Phone: 716-505-5700 Fax: 716-633-9351 | |
Tyler Whitaker, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7 Community Dr, Cheektowaga, NY 14225 Phone: 716-505-5651 | |
Amanda Lyn Moore, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 777 Maryvale Dr, Cheektowaga, NY 14225 Phone: 716-631-9515 | |
Samantha E Panfil, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4635 Union Rd, Cheektowaga, NY 14225 Phone: 716-505-5700 Fax: 716-933-9351 |